Next Steps Programs- Preclinical/Clinical Advancement of Cellular and Vaccine Therapies for Acral and Uveal Melanoma

This RFP will support preclinical, pre-IND development stage, and clinical-stage studies focused on advancing cellular or vaccine-based therapeutic approaches that have the potential to improved treatment strategies for patients with acral or uveal melanoma. 

Proposals on GNAQ/11 related melanomas are also allowed.

Funding: Pre clinical grant $100,000-$500,000 total ; Clinical trials #1,000,000 total 
Duration: 1-2 years 

Research Authority due date: 29.3.26

LOI (required) due date: 30.4.26

Full proposal due date: 16.6.26